Enter multiple symbols separated by commas

Stocks Herbalife Ltd


  • *No showing that Herbalife intended to defraud. *William Ackman made $1 billion bet against Herbalife. The lawsuit is separate from the campaign against Herbalife by billionaire activist investor William Ackman of Pershing Square Capital Management LP, who in December 2012 announced a $1 billion bet against the Los Angeles- based company.

  • Nov 25- A federal judge has dismissed a shareholder lawsuit against Herbalife Ltd and Chief Executive Officer Michael Johnson, claiming they misrepresented the weight-loss and nutritional products company's compliance with laws designed to prevent pyramid schemes. In a Nov. 23 decision, U.S. District Judge Dale Fischer in Los Angeles, who had dismissed two...

  • Nov 17- USPlabs, which sold the best-selling workout supplement Jack3d, and six of its executives face criminal charges for the unlawful sale of nutritional supplements, the U.S. Justice Department said Tuesday in announcing a larger probe by federal agencies aimed at stemming the sale of unproven products. The indictment says that USPlabs LLC used a...

  • NEW YORK, Nov 17- Shares of dietary supplement retailers tumbled in heavy trading volume on Tuesday, spurring a surge in options hedging activity for those stocks even though fears they would be mentioned in a U.S. Department of Justice lawsuit did not materialize. No specific companies were named in the announcement, but traders then sold off shares of GNC,...

  • News of the impending press conference earlier sent share prices of GNC Holdings Inc, Vitamin Shoppe and Herbalife Ltd lower. GNC Holdings closed down 6.4 percent, Vitamin Shoppe ended down 5 percent and Herbalife slipped 1.5 percent. Along with the Justice Department, the news conference was attended by representatives of the U.S. Food and Drug...

  • Shares of dietary supplement makers GNC Holdings Inc were down 24 percent in afternoon trading, while those of Vitamin Shoppe fell nearly 8 percent and Herbalife Ltd 2.5 percent. The DoJ said the news conference would be attended by representatives of the U.S. Food and Drug Administration, the U.S. Postal Inspection Service, the Federal Trade Commission, the...

  • Nov 17- Federal agencies including the Department of Justice and the health and anti-trust regulators will announce on Tuesday criminal and civil actions related to unlawful advertising and sale of dietary supplements. Shares of dietary supplement makers GNC Holdings Inc were down 20 percent, while those of Vitamin Shoppe fell nearly 8 percent and...

  • Global markets follow up on Wall Street rally Tuesday, 17 Nov 2015 | 6:49 AM ET

    World markets are higher this morning following Wall Street's best day in three weeks, and stock index futures point to more gains at the U.S. open.

  • Early movers: TWX, KORS, CBS, LL, HSIC, TSLA & more Wednesday, 4 Nov 2015 | 8:06 AM ET
    Traders work on the floor of the New York Stock Exchange (NYSE) on June 8, 2015 in New York City.

    Some of the names on the move ahead of the open.

  • Wall Street closes in on record territory Wednesday, 4 Nov 2015 | 7:54 AM ET

    U.S. stock futures were higher this morning, as the Dow, S&P 500, and Nasdaq near their record high closes of earlier this year.

  • After-hours buzz: Tesla, Groupon, Herbalife & more Tuesday, 3 Nov 2015 | 6:44 PM ET
    Trader on the floor of the New York Stock Exchange.

    Check out the companies making headlines after the bell Tuesday: Tesla, Etsy, Herbalife & more.

  • NEW YORK, Nov 3- Just before Bill Ackman gave a presentation on Friday to defend one of his biggest investments, Valeant Pharmaceuticals, from allegations of accounting and insurance fraud, he was taunted by John Hempton, who runs a small hedge fund from Australia. For Ackman's Pershing Square Capital Management hedge fund that is a scary thought.

  • Wall Street edgy after rally, more earnings ahead Tuesday, 3 Nov 2015 | 8:19 AM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stock index futures pointed to a lower open Tuesday, as investors paused for breath after the S&P 500 breached the 2,100-point level on Monday.

  • Street seeking early clues on year-end rally Monday, 2 Nov 2015 | 6:43 PM ET

    Traders will look for more signs Tuesday that the year-end rally still has more legs to run.

  • Markets to tune out Fed speakers in favor of data Friday, 30 Oct 2015 | 6:28 PM ET
    Trader on the floor of the New York Stock Exchange.

    Markets will be laser-focused on Friday's October jobs report in the week ahead and may even look past more than a dozen scheduled Fed speeches.

  • Oct 30- Valeant Pharmaceuticals International Inc, seeking to allay investor concerns about its business practices, said Friday it is cutting ties with a specialty pharmacy called Philidor Rx Services accused of helping it inflate revenue. The news failed to stem Valeant's sliding share price, which lost another 12 percent on Friday even after Bill Ackman,...

  • Oct 30- Valeant Pharmaceuticals International said on Friday that it is cutting ties with pharmacy Philidor Rx Services and that the pharmacy was shutting down. Bloomberg on Thursday detailed wrongdoing in its processing of medical claims, building on earlier reports about business practices. Express Scripts, CVS Health and OptumRx, part of UnitedHealth...

  • Bill Ackman: This is Valeant’s big mistake Friday, 30 Oct 2015 | 10:42 AM ET
    Bill Ackman

    Pershing Square Capital's Bill Ackman said Valeant Pharmaceuticals made a mistake by underinvesting in public, government, and investor relations.

  • BOSTON, Oct 21- A precipitous plunge in the stock price of Valeant Pharmaceuticals International Inc cost some of Wall Street's top names billions of dollars on Wednesday but hedge fund manager William Ackman took the meltdown as a buying opportunity. Pershing Square Holdings confirmed late on Wednesday that the company acquired in excess of two million...

  • The 'Icahn bottom'? Where his call for doom stands Friday, 9 Oct 2015 | 11:28 AM ET
    Carl Icahn

    When Carl Icahn put together an elaborate presentation on why he thought the stock market was in trouble, investors took notice — and started buying.